Ra Pharmaceuticals' Series B Round

Ra Pharmaceuticals raised a round of funding on July 23, 2015.

Ra Pharma combines novel insights into innate immunity with leadership in macrocycle technology to transform the lives of patients with life-threatening disorders. The company's proprietary peptide ch…

Articles about Ra Pharmaceuticals' Series B Round: